T. Rowe Price Group Inc.

Equities

TROW

US74144T1088

Investment Management & Fund Operators

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
116.9 ^USD	-0.65%		+0.74%	+8.56%

May. 10	Goldman Sachs Adjusts Price Target on T. Rowe Price Group to $110 From $112, Keeps Sell Rating	MT
May. 10	T. Rowe Price Group's Preliminary Assets Under Management Decline in April	MT

Endeavor BioMedicines, Inc. announced that it expects to receive $132.583908 million

April 21, 2024

Endeavor BioMedicines, Inc. announced that it will receive $132,583,908 in funding on April 22, 2024. The company will issue common stock in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.

Latest news about T. Rowe Price Group Inc.

Goldman Sachs Adjusts Price Target on T. Rowe Price Group to $110 From $112, Keeps Sell Rating	May. 10	MT
T. Rowe Price Group's Preliminary Assets Under Management Decline in April	May. 10	MT
ANALYST RECOMMENDATIONS : Blackrock, Walmart, Blackstone, Starbucks...	May. 10
Deutsche Bank Adjusts T. Rowe Price Group PT to $116 From $118	May. 10	MT
Evercore ISI Adjusts Price Target on T. Rowe Price Group to $107 From $110, In Line Rating Maintained	May. 09	MT
Bluejay Therapeutics, Inc. announced that it has received $182 million in funding from a group of investors	May. 08	CI
T. Rowe Price Group Keeps Quarterly Dividend at $1.24 a Share, Payable June 27 to Shareholders of Record June 14	May. 07	MT
T. Rowe Price Group, Inc. Declares Quarterly Dividend, Payable on June 27, 2024	May. 07	CI
T Rowe Price Group Insider Sold Shares Worth $344,102, According to a Recent SEC Filing	Apr. 30	MT
Autonomous Research Adjusts Price Target on T. Rowe Price Group to $94 From $96	Apr. 30	MT
JPMorgan Adjusts T. Rowe Price Group's Price Target to $102 From $103, Keeps Underweight Rating	Apr. 29	MT
UBS Adjusts T. Rowe Price Group Price Target to $112 From $109, Maintains Sell Rating	Apr. 29	MT
Jefferies Adjusts Price Target on T. Rowe Price to $120 From $122	Apr. 29	MT
Goldman Sachs Adjusts Price Target on T. Rowe Price Group to $112 From $111, Maintains Sell Rating	Apr. 29	MT
TD Cowen Adjusts Price Target on T. Rowe Price Group to $121 From $112, Keeps Hold Rating	Apr. 29	MT
Yen Hits 160 to Dollar in Thin Trade as Hopes for Near-Term BOJ Rate Hikes Wane	Apr. 29	DJ
Tranche Update on T. Rowe Price Group, Inc.'s Equity Buyback Plan announced on April 16, 2003.	Apr. 26	CI
Sector Update: Financial Stocks Steady Premarket Friday	Apr. 26	MT
T Rowe's quarterly profit beats estimates on tailwinds from market rally	Apr. 26	RE
Transcript : T. Rowe Price Group, Inc., Q1 2024 Earnings Call, Apr 26, 2024	Apr. 26
T. Rowe Price Group Q1 Adjusted Earnings, Net Revenue Rise	Apr. 26	MT
T. Rowe Price Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Endeavor BioMedicines, Inc. announced that it has received $127.5 million in funding from a group of investors	Apr. 23	CI
Endeavor BioMedicines, Inc. announced that it expects to receive $132.583908 million	Apr. 21	CI
T. Rowe Price says 2018 Tesla pay aligned with investor interests	Apr. 18	RE

Chart T. Rowe Price Group Inc.

Duration

Period

More charts

Company Profile

T. Rowe Price Group, Inc. is an investment management company that provides investment advisory services to individual and institutional investors, retirement plans, and financial intermediaries. The group manages a broad range of American and international stock, blended asset, bond, and money market mutual funds and other investment portfolios. T. Rowe Price Group also provides investment advisory clients with related administrative services, including mutual fund transfer agent, accounting and shareholder services, participant recordkeeping and transfer agent services for defined contribution retirement plans, discount brokerage, and trust services. At the end of 2023, the group had USD 1,444.5 billion in assets under management.

Sector

Investment Management & Fund Operators

Calendar

2024-06-13 - Ex-dividend day

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

According to Eric Veiel, CIO of T. Rowe Price: The financial sector has already reached full valuation

April 03, 2024 at 08:15 am EDT

More Strategies

Ratings for T. Rowe Price Group Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

116.9 USD

Average target price

115.3 USD

Spread / Average Target

-1.35%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Investment Management & Fund Operators

	1st Jan change	Capi.
T. ROWE PRICE GROUP INC.	+8.56%	26.11B
BLACKROCK, INC.	-3.36%	117B
UBS GROUP AG	+6.67%	97.97B
BROOKFIELD CORPORATION	+14.21%	68.65B
APOLLO GLOBAL MANAGEMENT, INC.	+21.20%	64.23B
BANK OF NEW YORK MELLON CORPORATION (THE)	+12.07%	43.62B
AMERIPRISE FINANCIAL, INC.	+14.30%	43.12B
3I GROUP PLC	+21.89%	35.88B
STATE STREET CORPORATION	-3.42%	22.54B
PRINCIPAL FINANCIAL GROUP, INC.	+3.50%	19.08B

Other Investment Management & Fund Operators